SCHEMBL21263632

SCHEMBL21263632

N=Cc1c(NPI)ccc(Cl)c1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24652759 0.79 — —
SCHEMBL24373166 0.79 MEN1 (0.37) —
SCHEMBL24933454 0.75 — —
SCHEMBL24305375 0.67 TSHR (0.32) —
SCHEMBL24652651 0.64 — —
SCHEMBL24652646 0.63 — —
SCHEMBL172044 0.56 CYP3A4 (0.36) —
SCHEMBL22873524 0.55 — —
SCHEMBL20437526 0.55 TTR (0.33) —
SCHEMBL23647903 0.55 ALDH1A1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019155399-A1 TETRAHYDROQUINAZOLINE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER INC. (US) 2019-08-15 — — WO disclosed
Send feedback